{
    "Trade/Device Name(s)": [
        "TrueDX hCG Early Result Pregnancy Test (Midstream Format)",
        "TrueDX hCG Early Result Pregnancy Test (Cassette Format)",
        "VeriClear Early Result Pregnancy Test (Midstream Format)",
        "VeriClear Early Result Pregnancy Test (Cassette Format)"
    ],
    "Submitter Information": "True Diagnostics, Inc.",
    "510(k) Number": "K172257",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123436"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI",
        "LCX"
    ],
    "Summary Letter Date": "November 7, 2017",
    "Summary Letter Received Date": "November 9, 2017",
    "Submission Date": "December 20, 2017",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)",
        "Intact hCG",
        "Hyperglycosylated hCG",
        "hCG \u03b2-subunit"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Qualitative chromatographic immunoassay",
        "Lateral flow sandwich immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Cassette",
        "Midstream device"
    ],
    "Document Summary": "FDA 510(k) summary for TrueDX and VeriClear Early Result Pregnancy Tests for qualitative detection of hCG in urine using chromatographic immunoassay",
    "Indications for Use Summary": "Rapid qualitative detection of human chorionic gonadotropin (hCG) in urine as an aid in early detection of pregnancy, as early as five days before the expected period",
    "fda_folder": "Clinical Chemistry"
}